Jones Jon M DDS ,
-
Prediabetes on Medicare in 2026: MDPP or GLP-1 Bridge First?
Medicare’s GLP-1 Bridge began July 1, 2026, but it is separate from Medicare’s diabetes-prevention benefit. A new JAMA follow-up, current CMS rules, and ADA guidance help explain why structured lifestyle treatment still remains the usual first step for many older adults with prediabetes.
-
Alzheimer’s Disease: New Anti-Amyloid Antibody Drugs Slow Cognitive Decline
Researchers are making progress: new monoclonal antibody medicines that target amyloid plaques can modestly slow memory and thinking decline in some people with early Alzheimer’s. While not a cure, this can help patients and caregivers plan ahead and discuss with a healthcare provider who might qualify, the potential benefits and risks, and what monitoring and coverage are needed.
-
Innovation Unleashed: The Transformation and Challenges of Personalized Medicine
Shaping Tomorrow: Personalized Medicine’s Transformation, Challenges, and the Innovative Future of Healthcare Personalized medicine is on the brink of transforming healthcare, but it’s not without its challenges. As we peer…
-
How to Measure and Monitor Blood Pressure at Home
Regular monitoring fosters proactive health management.
